Lutathera is a prescription drug that’s used to treat certain rare tumors. It’s given as an intravenous (IV) infusion by a healthcare professional. Lutathera is used in adults and certain children to ...
Saint-Genis-Pouilly, France, March 25, 2020 - Advanced Accelerator Applications S.A. (AAA), a Novartis company, today announced that the first patient has been treated in the NETTER-2 Phase III ...
Lutathera plus Sandostatin improved progression-free survival in patients with advanced gastric neuroendocrine tumors, research showed. Patients with advanced gastric neuroendocrine tumors (NETs) who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results